ABT vs. OGN
Compare and contrast key facts about Abbott Laboratories (ABT) and Organon & Co. (OGN).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABT or OGN.
Key characteristics
| ABT | OGN | |
|---|---|---|
| YTD Return | -2.78% | 31.04% |
| 1Y Return | -2.69% | -18.88% |
| Sharpe Ratio | -0.12 | -0.45 |
| Daily Std Dev | 17.89% | 42.71% |
| Max Drawdown | -45.62% | -69.56% |
| Current Drawdown | -21.55% | -47.48% |
Fundamentals
| ABT | OGN | |
|---|---|---|
| Market Cap | $186.58B | $4.74B |
| EPS | $3.22 | $3.99 |
| PE Ratio | 33.39 | 4.65 |
| PEG Ratio | 5.99 | 0.00 |
| Revenue (TTM) | $40.33B | $6.26B |
| Gross Profit (TTM) | $24.58B | $3.89B |
| EBITDA (TTM) | $10.34B | $1.56B |
Correlation
The correlation between ABT and OGN is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABT vs. OGN - Performance Comparison
In the year-to-date period, ABT achieves a -2.78% return, which is significantly lower than OGN's 31.04% return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABT vs. OGN - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Organon & Co. (OGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABT vs. OGN - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.00%, less than OGN's 6.02% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.00% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% | 1.95% | 1.46% |
OGN Organon & Co. | 6.02% | 7.77% | 4.01% | 1.84% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
ABT vs. OGN - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.62%, smaller than the maximum OGN drawdown of -69.56%. Use the drawdown chart below to compare losses from any high point for ABT and OGN. For additional features, visit the drawdowns tool.
Volatility
ABT vs. OGN - Volatility Comparison
The current volatility for Abbott Laboratories (ABT) is 5.10%, while Organon & Co. (OGN) has a volatility of 7.65%. This indicates that ABT experiences smaller price fluctuations and is considered to be less risky than OGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABT vs. OGN - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Organon & Co.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities